Mounjaro 10 mg Price: What Private Treatment Actually Costs in the UK

You've hit 10 mg and the invoice is in front of you

Picture the moment: you've spent several months on Mounjaro, you've tolerated the earlier doses well, and your prescriber has moved you up to 10 mg. Then you look at the cost and notice it's higher than you were paying at 2.5 mg or 5 mg. That's expected. Tirzepatide pens are priced per strength in the private market, and 10 mg sits towards the upper end of the licensed schedule, only 12.5 mg and 15 mg sit above it. Eli Lilly adjusted Mounjaro's UK list prices substantially from 1 September 2025; as widely reported, the highest-dose pen's list price rose from around £122 to around £330, and mid-range doses followed a similar upward trajectory. What that means in practice is that private 10 mg Mounjaro price in the UK now reflects a meaningfully different cost base than it did before that change.

What it does not mean is that every provider charges the same. The figure you see quoted on a website may or may not include the clinical consultation, the prescription, aftercare support, or delivery. Those aren't small extras, for a fuller picture of how Mounjaro pricing works across the dose range, the structure of what's bundled in (or not) matters as much as the headline number. A price that looks lower often has more items sitting outside it.

What the headline price on a competitor's page often leaves out

This is the part of the 10 mg Mounjaro price conversation that doesn't get enough attention. A single quoted figure typically covers the pen. What it may not cover: the initial clinical consultation (some providers charge £25–£50 for this separately), the repeat prescription review before each subsequent order, delivery (often £5–£10 per shipment), and any follow-up support if you have questions about side effects or a missed dose. Add those up across a month and the gap between a seemingly cheaper listing and an all-in price narrows, sometimes closes entirely, sometimes tips the other way.

There's also the question of what a clinical review actually consists of. A video weight verification, a photo-ID check, a review of your GP record where appropriate, and a prescriber reading your answers personally are not the same thing as an automated eligibility tick-box. More detail on what drives the 10 mg cost and how to compare providers fairly is worth reading before you commit to any service. The lowest number is rarely the full story.

Where nume sits on price, and why we're transparent about it

We're not going to be the cheapest option you find. That's a deliberate choice, not an oversight. One transparent price covers the clinical consultation, the prescription, the treatment itself, and next-working-day delivery by DPD, tracked to your door in a plain box with nothing on the outside to indicate what's inside. There are no subscription fees, no auto-renewals, and no bill for aftercare. Every repeat order goes through a fresh clinical review by a real prescriber before anything is dispatched.

Our pharmacy is GPhC-registered (registration number 9012878, verifiable directly at the GPhC register), and every consultation is personally reviewed by a GPhC-registered Independent Prescriber the same day. What the current treatment price is for any specific dose, including 10 mg, is shown clearly on our treatment page, we don't print it in articles because prices in this market move, and we'd rather you see the live figure than one that's weeks out of date.

For a prescription medicine, price is the wrong starting point

The MHRA has been explicit: GLP-1 medicines sold without a valid prescription and proper clinical assessment are a public health risk. Large seizures of counterfeit tirzepatide pens have been made in the UK (including an illicit manufacturing site raided in 2025) and fake pens have been found to contain substances including insulin. The MHRA's Yellow Card scheme accepts reports of suspected counterfeit or illegally sold medicines, and the regulator has warned consumers that prices far below the market rate, sellers on social media, and offers that bypass clinical assessment are red flags, not bargains.

A useful frame: tirzepatide at 10 mg is a step in a clinically supervised titration that a prescriber has judged appropriate for you specifically. The pen that arrives is part of an ongoing clinical relationship. Clinical trial evidence on what 10 mg and higher doses achieve gives context for why the dose progression matters, and why the review at each step is there for a reason, not as a formality. The right question isn't which provider is cheapest. It's which provider is actually running a service that keeps you safe.

If you're comparing costs across the dose range, the 5 mg price context and the 7.5 mg price context follow the same structure, useful if you're planning ahead or considering where you are in the titration schedule. For a broader look at what tirzepatide treatment involves, our Mounjaro overview covers the mechanism, eligibility, and how the process works from consultation to delivery. Our clinical team oversees every prescription personally.